140 related articles for article (PubMed ID: 36178468)
21. Xenobiotic-metabolizing enzymes in Bacillus anthracis: molecular and functional analysis of a truncated arylamine N-acetyltransferase isozyme.
Kubiak X; Duval R; Pluvinage B; Chaffotte AF; Dupret JM; Rodrigues-Lima F
Br J Pharmacol; 2017 Jul; 174(14):2174-2182. PubMed ID: 27846346
[TBL] [Abstract][Full Text] [Related]
22. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
23. FDB2 encodes a member of the arylamine N-acetyltransferase family and is necessary for biotransformation of benzoxazolinones by Fusarium verticillioides.
Glenn AE; Bacon CW
J Appl Microbiol; 2009 Aug; 107(2):657-71. PubMed ID: 19302487
[TBL] [Abstract][Full Text] [Related]
24. The Bacillus anthracis arylamine N-acetyltransferase ((BACAN)NAT1) that inactivates sulfamethoxazole, reveals unusual structural features compared with the other NAT isoenzymes.
Pluvinage B; Li de la Sierra-Gallay I; Kubiak X; Xu X; Dairou J; Dupret JM; Rodrigues-Lima F
FEBS Lett; 2011 Dec; 585(24):3947-52. PubMed ID: 22062153
[TBL] [Abstract][Full Text] [Related]
25. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
[TBL] [Abstract][Full Text] [Related]
26. An update on genetic, structural and functional studies of arylamine N-acetyltransferases in eucaryotes and procaryotes.
Sim E; Payton M; Noble M; Minchin R
Hum Mol Genet; 2000 Oct; 9(16):2435-41. PubMed ID: 11005799
[TBL] [Abstract][Full Text] [Related]
27. Molecular and Functional Characterization of
Uno Y; Uehara S; Ijiri M; Kawaguchi H; Asano A; Shiraishi M; Banju K; Murayama N; Yamazaki H
Drug Metab Dispos; 2022 Nov; 50(11):1429-1433. PubMed ID: 35768074
[TBL] [Abstract][Full Text] [Related]
28. Molecular and Functional Characterization of N-Acetyltransferases NAT1 and NAT2 in Cynomolgus Macaque.
Uno Y; Murayama N; Yamazaki H
Chem Res Toxicol; 2018 Nov; 31(11):1269-1276. PubMed ID: 30358977
[TBL] [Abstract][Full Text] [Related]
29. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
30. From arylamine N-acetyltransferase to folate-dependent acetyl CoA hydrolase: impact of folic acid on the activity of (HUMAN)NAT1 and its homologue (MOUSE)NAT2.
Laurieri N; Dairou J; Egleton JE; Stanley LA; Russell AJ; Dupret JM; Sim E; Rodrigues-Lima F
PLoS One; 2014; 9(5):e96370. PubMed ID: 24823794
[TBL] [Abstract][Full Text] [Related]
31. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.
Hein DW; Doll MA; Rustan TD; Gray K; Feng Y; Ferguson RJ; Grant DM
Carcinogenesis; 1993 Aug; 14(8):1633-8. PubMed ID: 8353847
[TBL] [Abstract][Full Text] [Related]
32. The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress.
Dairou J; Malecaze F; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2005 Apr; 67(4):1299-306. PubMed ID: 15644493
[TBL] [Abstract][Full Text] [Related]
33. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
[TBL] [Abstract][Full Text] [Related]
34. A fragment consisting of the first 204 amino-terminal amino acids of human arylamine N-acetyltransferase one (NAT1) and the first transacetylation step of catalysis.
Sinclair J; Sim E
Biochem Pharmacol; 1997 Jan; 53(1):11-6. PubMed ID: 8960058
[TBL] [Abstract][Full Text] [Related]
35. Expression of arylamine N-acetyltransferase in human intestine.
Hickman D; Pope J; Patil SD; Fakis G; Smelt V; Stanley LA; Payton M; Unadkat JD; Sim E
Gut; 1998 Mar; 42(3):402-9. PubMed ID: 9577349
[TBL] [Abstract][Full Text] [Related]
36. Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention.
Sim E; Fakis G; Laurieri N; Boukouvala S
Adv Pharmacol; 2012; 63():169-205. PubMed ID: 22776642
[TBL] [Abstract][Full Text] [Related]
37. Modulation of Human Arylamine
Butcher NJ; Burow R; Minchin RF
Mol Pharmacol; 2020 Aug; 98(2):88-95. PubMed ID: 32487734
[TBL] [Abstract][Full Text] [Related]
38. Structure and regulation of the drug-metabolizing enzymes arylamine N-acetyltransferases.
Dupret JM; Rodrigues-Lima F
Curr Med Chem; 2005; 12(3):311-8. PubMed ID: 15723621
[TBL] [Abstract][Full Text] [Related]
39. Arylamine N-acetyltransferase polymorphisms in Han Chinese patients with ankylosing spondylitis and their correlation to the adverse drug reactions to sulfasalazine.
Hou ZD; Xiao ZY; Gong Y; Zhang YP; Zeng QY
BMC Pharmacol Toxicol; 2014 Nov; 15():64. PubMed ID: 25413361
[TBL] [Abstract][Full Text] [Related]
40. Folate-Dependent Hydrolysis of Acetyl-Coenzyme A by Recombinant Human and Rodent Arylamine N-Acetyltransferases.
Stepp MW; Mamaliga G; Doll MA; States JC; Hein DW
Biochem Biophys Rep; 2015 Sep; 3():45-50. PubMed ID: 26309907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
